| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Mu-type opioid receptor |
|---|
| Ligand | BDBM364561 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Mu-Opioid Receptor Binding Assay |
|---|
| Ki | 0.056±0.01 nM |
|---|
| Citation |  Youngman, M Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans US Patent US9862726 Publication Date 1/9/2018 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Mu-type opioid receptor |
|---|
| Name: | Mu-type opioid receptor |
|---|
| Synonyms: | M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1 |
|---|
| Type: | G Protein-Coupled Receptor (GPCR) |
|---|
| Mol. Mass.: | 44789.51 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P35372 |
|---|
| Residue: | 400 |
|---|
| Sequence: | MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCP
PTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALAT
STLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDF
RTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFI
FAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHI
YVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNI
EQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
|
|
|
|---|
| BDBM364561 |
|---|
| n/a |
|---|
| Name | BDBM364561 |
|---|
| Synonyms: | N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-hydroxy-5,6,7,8,9,10-hexahydro-9,4b- (epiminoethano)-8a,6- (epoxymethano)phenanthren-6- yl)pivalamide | US9862726, Compound 26 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H36N2O3 |
|---|
| Mol. Mass. | 424.5756 |
|---|
| SMILES | CC(C)(C)C(=O)NC12CC[C@@]3(OC1)[C@H]1Cc4ccc(O)cc4[C@@]3(CCN1CC1CC1)C2 |r,TLB:26:25:10:21.15.14| |
|---|
| Structure | 
|
|---|
Search and Browse
